Mechanism of Action
Delta Sleep-Inducing Peptide (DSIP) is a multifunctional regulatory peptide that interacts with various neurotransmitter systems to exert its effects. Its primary mechanism involves modulating the activity of GABAergic neurons, which are crucial for promoting relaxation and sleep. DSIP also influences the release of corticotropin-releasing hormone (CRH), thereby regulating the hypothalamic-pituitary-adrenal (HPA) axis and mitigating stress responses. Additionally, DSIP has been shown to enhance the secretion of gro*wth hor*mo*ne-releasing hormone (G*H*R*H) and somatotropin, which are vital for tissue repair and metabolic regulation. In the context of sleep, DSIP increases slow-wave sleep (SWS) duration by acting on specific brain regions such as the hypothalamus and thalamus, which are integral to sleep regulation.
Applications and Future Prospects
DSIP holds significant promise in the medical field due to its diverse physiological effects. Its primary application is in the treatment of sleep disorders, where it has demonstrated efficacy in enhancing deep sleep and improving overall sleep quality. This makes DSIP a potential therapeutic agent for conditions such as insomnia and sleep apnea. Beyond sleep therapy, DSIP's stress-protective properties suggest its use in managing stress-related disorders. Its ability to modulate the HPA axis and reduce corticotropin levels indicates potential applications in treating anxiety and depression. Furthermore, DSIP's neuroprotective effects, evidenced by its ability to reduce neuronal damage in ischemic conditions, point towards its use in neurodegenerative diseases such as Alzheimer's and Parkinson's. Ongoing research is also exploring DSIP's potential in enhancing cognitive function and physical performance, making it a subject of interest in sports medicine and anti-aging therapies.
| Product Name |
Delta Sleep-Inducing Peptide |
| Active Ingredient |
DSIP Injection |
| Dosage Form |
Injection |
| Strength |
5mg per vial |
| Diluent |
10 ml sterile water for injection |
| Route of Administration |
Intravenous (IV) or Intramuscular (IM) |
| Packaging |
1 vial (Delta 5 mg) + 1 injection vial (10ml sterile water for injection) |
| Manufacturer |
Sinopharmatech Co., Ltd. |
Research Progress
Research on DSIP has spanned several decades, with initial studies focusing on its sleep-inducing properties. Early experiments demonstrated that DSIP could increase spindle wave activity and induce delta brainwave patterns, characteristic of deep sleep. Subsequent investigations have delved into DSIP's impact on stress and anxiety, revealing its ability to normalize brain metabolism and reduce stress-induced oxidative damage. Recent studies have also explored DSIP's role in modulating the immune system and its potential as an adaptogen, capable of normalizing physiological functions under stress. Clinical trials are ongoing to further elucidate DSIP's efficacy and safety profile in various medical applications.
Dosage and Administration
The optimal dosage of DSIP varies depending on the intended use and individual response. For sleep enhancement, a common recommendation is 200 micrograms administered subcutaneously 1-3 hours before bedtime. In research settings, doses ranging from 40 to 360 micrograms have been used to study DSIP's effects on stress and antioxidant activity. It is important to note that DSIP's effects can be dose-dependent, with higher doses potentially leading to different outcomes. Therefore, careful titration and monitoring are advised to achieve the desired therapeutic effects while minimizing potential side effects.
Storage Conditions
Proper storage is essential to maintain the stability and efficacy of DSIP. The peptide should be stored in a sealed container, protected from moisture and light. In its dry powder form, DSIP can be preserved at -80°C for up to 2 years and at -20°C for 1 year. Once reconstituted, DSIP solutions should be stored at -80°C for up to 6 months or at -20°C for 1 month. Reconstituted solutions should be used promptly to ensure maximum effectiveness.
Conclusion
Delta Sleep-Inducing Peptide (DSIP) is a versatile peptide with a wide range of potential applications in sleep medicine, stress management, and neuroprotection. Its unique mechanism of action, involving modulation of multiple neurotransmitter systems, positions DSIP as a promising candidate for addressing various medical conditions. Ongoing research continues to explore DSIP's therapeutic potential, with clinical trials aiming to establish its safety and efficacy in diverse medical applications. As understanding of DSIP's effects deepens, it may become an integral part of future treatment strategies for sleep disorders, stress-related conditions, and neurodegenerative diseases.
Support different package method
For more information, please feel free to contact us.
Why Choose Us?
High Purity (≥98%)
Flexible Dosing Options
GMP-Certified Quality
Weekly Dosing for Convenience
Audited Supplier 
){kind=link}